CLINICAL_TRIALS
trial_result
· 2019-07-26
Clinical Trial Update: Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) [Phase 1]
Summary
Phase 1 study evaluating safety and pharmacokinetics of intravenous and oral posaconazole in immunocompromised children with neutropenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Neutropenia | Phase 1 | Status: COMPLETED | Results posted: 2019-07-26